Improved Survival of CAR‐T and Tumor‐specific T Cells Caused by Anti‐PD‐1 scFv‐producing CAR‐T Cells

Cancer Science - United States
doi 10.1111/cas.14169
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Anti-Car-Engineered T Cells for Epitope-Based Elimination of Autologous CAR T Cells

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Engineering CAR-T Cells

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2017English

Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells

Cancer immunology research
Cancer ResearchImmunology
2015English

Targeting Glioblastoma With CAR T Cells

Cancer Discovery
Oncology
2017English

A Spheroid Killing Assay by CAR T Cells

Journal of Visualized Experiments
ImmunologyMolecular BiologyBiochemistryMicrobiology Chemical EngineeringNeuroscienceGenetics
2018English

CAR T-Cells: Costs, Comparisons and Commentary

Journal of Medical Economics
Health Policy
2019English

Tracing the Path of CAR T Cells

Cancer Discovery
Oncology
2017English

TEM8/ANTXR1-specific CAR T Cells Mediate Toxicity in Vivo

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy